Genetic variations in toll-like receptors 7 and 8 modulate natural hepatitis C outcomes and liver disease progression

Liver International

Volumn 38, Issue 3, 2018, Pages 432-442

  Fakhir, Fatima Zohra ^a,b   Lkhider, Mustapha ^c   Badre, Wafaa ^d   Alaoui, Rhimou ^d   Meurs, Eliane F ^e   Pineau, Pascal ^e   Ezzikouri, Sayeh ^a   Benjelloun, Soumaya ^a  

^a Institut Pasteur du Maroc   (Morocco)

^b FACULTÉ DES SCIENCES   (Morocco)

^c HASSAN II UNIVERSITY OF CASABLANCA   (Morocco)

^d IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

^e INSTITUT PASTEUR   (France)

Author keywords

hepatitis C virus; hepatocellular carcinoma; TLR7; TLR8

Indexed keywords

TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TLR7 PROTEIN, HUMAN; TLR8 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CHRONIC HEPATITIS; CLINICAL OUTCOME; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; GENETIC VARIATION; GENOTYPE; HEPATITIS C; HETEROZYGOTE; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOROCCAN; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL CLEARANCE; AGED; GENE FREQUENCY; GENETICS; LIVER; PATHOPHYSIOLOGY; SEX FACTOR; STATISTICAL MODEL;

AGED; ALLELES; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENETIC VARIATION; GENOTYPE; HEPATITIS C; HUMANS; LIVER; LOGISTIC MODELS; MALE; MIDDLE AGED; SEX FACTORS; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 8;

EID: 85042375553     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.13533     Document Type: Article

References (40)

1. Thomas DL, Astemborski J, Rai RM, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA. 2000;284:450-456.
2. Cooper S, Erickson AL, Adams EJ, et al. Analysis of a successful immune response against hepatitis C virus. Immunity. 1999;10:439-449.
3. Heil F, Hemmi H, Hochrein H, et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 2004;303:1526-1529.
4. Seki E, Brenner DA. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology. 2008;48:322-335.
5. Ito T, Amakawa R, Fukuhara S. Roles of toll-like receptors in natural interferon-producing cells as sensors in immune surveillance. Hum Immunol. 2002;63:1120-1125.
6. Horsmans Y, Berg T, Desager JP, et al. Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection. Hepatology. 2005;42:724-731.
7. Huang WS, Lu SN, Wang JH, et al. Prediction of viremia for cases of hepatitis C virus (HCV) infection using a third-generation anti-HCV enzyme immunoassay test. Hepatogastroenterology. 2005;52:893-896.
8. Lee J, Tian Y, Chan ST, Kim JY, Cho C, Ou JHJ. TNF-α induced by hepatitis C virus via TLR7 and TLR8 in hepatocytes supports interferon signaling via an autocrinemechanism. PLoS Pathog. 2015;11:e1004937.
9. Wang CH, Eng HL, Lin KH, et al. TLR7 and TLR8 gene variations and susceptibility to hepatitis C virus infection. PLoS ONE. 2011;6:e26235.
10. Wang CH, Eng HL, Lin KH, Liu HC, Chang CH, Lin TM. Functional polymorphisms of TLR8 are associated with hepatitis C virus infection. Immunology. 2014;141:540-548.
11. Schott E, Witt H, Neumann K, et al. Association of TLR7 single nucleotide polymorphisms with chronic HCV-infection and response to interferon-a-based therapy. J Viral Hepat. 2008;15:71-78.
12. Du X, Poltorak A, Wei Y, Beutler B. Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur Cytokine Netw. 2000;11:362-371.
13. Cheng PL, Eng HL, Chou MH, You HL, Lin TM. Genetic polymorphisms of viral infection-associated Toll-like receptors in Chinese population. Transl Res. 2007;150:311-318.
14. Oh DY, Taube S, Hamouda O, et al. A functional toll-like receptor 8 variant is associated with HIV disease restriction. J Infect Dis. 2008;198:701-709.
15. Davila S, Hibberd ML, Hari Dass R, et al. Genetic association and expression studies indicate a role of toll-like receptor 8 in pulmonary tuberculosis. PLoS Genet. 2008;4:e1000218.
16. Fakhir FZ, Lkhider M, Badre W, et al. The -94Ins/DelATTG polymorphism in NFκB1 promoter modulates chronic hepatitis C and liver disease progression. Infect Genet Evol. 2016;39:141-146.
17. Brahim I, Akil A, Mtairag EM, et al. Morocco underwent a drift of circulating hepatitis C virus subtypes in recent decades. Arch Virol. 2012;157:515-520.
18. Ezzikouri S, Rebbani K, Fakhir FZ, et al. The allele 4 of neck region liver-lymph node-specific ICAM-3-grabbing integrin variant is associated with spontaneous clearance of hepatitis C virus and decrease of viral loads. Clin Microbiol Infect. 2014;20:O325-O332.
19. Ezzikouri S, Pineau P, Benjelloun S. Hepatitis C virus infection in the Maghreb region. J Med Virol. 2013;85:1542-1549.
20. Chung H, Watanabe T, Kudo M, Chiba T. Correlation between hyporesponsiveness to toll-like receptor ligands and liver dysfunction in patients with chronic hepatitis C virus infection. J Viral Hepat. 2011;18:e561-e567.
21. Wedemeyer H, He XS, Nascimbeni M, et al. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol. 2002;169:3447-3458.
22. Gorden KB, Gorski KS, Gibson SJ, et al. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J Immunol. 2005;174:1259-1268.
23. Rauch A, Gaudieri S, Thio C, Bochud PY. Host genetic determinants of spontaneous hepatitis C clearance. Pharmacogenomics. 2009;10:1819-1837.
24. Coccia EM, Severa M, Giacomini E, et al. Viral infection and toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol. 2004;34:796-805.
25. Ito T, Wang YH, Liu YJ. Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by toll-like receptor (TLR) 7 and TLR9. Springer Semin Immunopathol. 2005;26:221-229.
26. Horsmans Y. Chronic hepatitis C, depression and interferon. J Hepatol. 2005;42:788-789.
27. Zhang YL, Guo YJ, Bin Li, Sun SH. Hepatitis C virus single-stranded RNA induces innate immunity via toll-like receptor 7. J Hepatol. 2009;51:29-38.
28. Thomas A, Laxton C, Rodman J, Myangar N, Horscroft N, Parkinson T. Investigating toll-like receptor agonists for potential to treat hepatitis C virus infection. Antimicrob Agents Chemother. 2007;51:2969-2978.
29. Askar E, Ramadori G, Mihm S. Toll-like receptor 7 rs179008/Gln11Leu gene variants in chronic hepatitis C virus infection. J Med Virol. 2010;82:1859-1868.
30. Møller-Larsen S, Nyegaard M, Haagerup A, Vestbo J, Kruse TA, Børglum AD. Association analysis identifies TLR7 and TLR8 as novel risk genes in asthma and related disorders. Thorax. 2008;63:1064-1069.
31. Rutkowski DT, Ott CM, Polansky JR, Lingappa VR. Signal sequences initiate the pathway of maturation in the endoplasmic reticulum lumen. J Biol Chem. 2003;278:30365-30372.
32. Holden P, Keene DR, Lunstrum GP, Bächinger HP, Horton WA. Secretion of cartilage oligomeric matrix protein is affected by the signal peptide. J Biol Chem. 2005;280:17172-17179.
33. Rutkowski DT, Lingappa VR, Hegde RS. Substrate-specific regulation of the ribosome- translocon junction by N-terminal signal sequences. Proc Natl Acad Sci USA. 2001;98:7823-7828.
34. Ott CM, Lingappa VR. Signal sequences influence membrane integration of the prion protein. Biochemistry. 2004;43:11973-11982.
35. Hedge RS, Bernstein HD. The surprising complexity of signal sequences. Trends Biochem Sci. 2006;31:563-571.
36. Oh DY, Baumann K, Hamouda O, et al. A frequent functional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression. AIDS. 2009;23:297-307.
37. Yue M, Gao CF, Wang JJ, et al. Toll-like receptor 7 variations are associated with the susceptibility to HCV infection among Chinese females. Infect Genet Evol. 2014;27:264-270.
38. Sharp A, Robinson D, Jacobs P. Age- and tissue-specific variation of X chromosome inactivation ratios in normal women. Hum Genet. 2000;107:343-349.
39. Cholet F, Nousbaum JB, Richecoeur M, et al. Factors associated with liver steatosis and fibrosis in chronic hepatitis C patients. Gastroenterol Clin Biol. 2004;28:272-278.
40. Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol. 2001;34:730-739.